Sage Therapeutics Inc (DELISTED) (SAGE:DL)
8.68
0.00 (0.00%)
USD |
NASDAQ |
Aug 04, 16:00
Sage Therapeutics EPS Diluted (Quarterly): -0.793 for June 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Supernus Pharmaceuticals, Inc. | -0.7978 |
| Biogen, Inc. | 3.171 |
| Eli Lilly & Co. | 6.211 |
| Sarepta Therapeutics, Inc. | -1.795 |
| IGM Biosciences, Inc. (DELISTED) | 1.580 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -49.65M |
| Revenue (Quarterly) | 31.66M |
| Total Expenses (Quarterly) | 81.31M |
| Enterprise Value | 179.37M |
| Profit Margin (Quarterly) | -156.8% |
| Earnings Yield | -56.34% |
| Normalized Earnings Yield | -52.17 |